Aether Industries Limited Share Price & Stock Analysis

Aether Industries Limited (NSE: AETHER, BSE: 543534) is a Surat, Gujarat-based company in the Pharmaceutical Contract Manufacturing Services industry. With a market capitalisation of ₹21,710 Cr, it ranks #356 by market cap among the 6,197 Indian listed companies on FinBizNet, and #2 of 26 in Pharmaceutical Contract Manufacturing Services. At ₹1,682.10 (as of 16 Nov 2026), the share price is 7.3% below its 52-week high of ₹1,814.10 and 110.1% above its 52-week low of ₹800.45. The share price is up 127.8% over one year and up 6.1% over three months.

Key Metrics

Current Price₹1,682.10
Market Cap₹21,710 Cr
NSE SymbolAETHER
BSE Code543534
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryPharmaceuticals > Pharmaceutical Contract Manufacturing Services
P/E Ratio101.8
Return on Equity9.81%
Return on Assets6.36%
52-Week Range₹800.45 – ₹1,814.10
1-Year Price Change+127.8%
3-Month Price Change+6.1%
Beta (1Y)0.19
HeadquartersSurat, Gujarat
Websitewww.aether.co.in

Latest Quarterly Results — Q2 FY27

Revenue₹347 Cr
Net Profit₹68 Cr
Net Margin19.6%
EPS (Basic)₹5.12
Basisconsolidated

Figures in ₹ crore, parsed from the company's exchange filing (XBRL).

Aether Industries Limited Quarterly Revenue and Profit Trend

Aether Industries Limited reported revenue of ₹347 Cr in Q2 FY27, up 26.2% from ₹275 Cr in Q2 FY26 and up 6.3% from ₹327 Cr in Q1 FY27. It posted a net profit of ₹68 Cr for the quarter, against a net profit of ₹54 Cr in Q2 FY26 (up 26.0%). Across the 7 quarters from Q4 FY25 to Q2 FY27, quarterly revenue ranged from ₹240 Cr (Q4 FY25) to ₹347 Cr (Q2 FY27). The company was profitable in each of these 7 quarters.

QuarterRevenueNet ProfitNet Margin
Q2 FY27₹347 Cr₹68 Cr19.6%
Q1 FY27₹327 Cr₹63 Cr19.2%
Q4 FY26₹305 Cr₹54 Cr17.7%
Q3 FY26₹317 Cr₹64 Cr20.3%
Q2 FY26₹275 Cr₹54 Cr19.6%
Q1 FY26₹256 Cr₹47 Cr18.4%
Q4 FY25₹240 Cr₹50 Cr20.9%

Consolidated figures (₹ crore, XBRL filings).

Shareholding and Delivery

Promoters held 74.92% of Aether Industries Limited's shares as of Sept 2026, against 75.00% in Sept 2025 (−0.08 percentage points). Delivery averaged 43.7% of traded volume across 16 NSE sessions (22 Oct 2026 – 13 Nov 2026).

About Aether Industries Limited

Aether Industries Limited produces and sells advanced intermediates and specialty chemicals in India and internationally. It also large-scale manufacturing, contract research and manufacturing services, as well as contract/exclusive manufacturing services. The company serves its products to the chemical industry, including multinational, regional, and domestic companies in the pharmaceuticals, agrochemicals, materials science, textiles, coatings, high-performance photography, additives, and oil and gas industries. It also exports its products. Aether Industries Limited was incorporated in 2013 and is headquartered in Surat, India.

Products and Services

1. Contract Manufacturing-This segment engages in the contract manufacturing of specialty chemicals and intermediates. 2. Contract Research and Manufacturing Services (CRAMS)-This segment provides contract research and manufacturing services. 3. Others-0 4. Large Scale Manufacturing-This segment manufactures specialty chemicals and intermediates.

Business Segments

1. Contract/Exclusive Manufacturing-46.3% 2. Large Scale Manufacturing-43.2% 3. CRAMS-9.2% 4. Others-1.3%

Aether Industries Limited vs Peers — Pharmaceutical Contract Manufacturing Services

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Torrent Pharma Ltd.₹1,79,494 Cr73.616.98%₹4,979 Cr+30.4%
Aether Industries Limited₹21,710 Cr101.89.81%₹347 Cr+127.8%
Alivus Life Sciences Ltd₹17,862 Cr31.518.36%₹682 Cr+64.0%
Aarti Pharmalabs Ltd₹8,374 Cr52.58.49%₹610 Cr+15.4%
Solara Active Pharma Sciences Limited₹3,225 Crn/m-0.63%₹417 Cr+22.1%
Sai Parenteral's Limited₹2,235 Cr115.82.88%₹195 Cr—
KRM Ayurveda Limited₹521 Cr25.917.54%₹32 Cr—
Trident Lifeline Limited₹511 Cr26——+37.6%
Infinium Pharmachem Limited₹436 Cr36.410.54%—+11.7%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Aether Industries Limited?

Aether Industries Limited is trading at ₹1,682.10, with a market capitalisation of ₹21,710 Cr.

Which sector does Aether Industries Limited belong to?

Aether Industries Limited operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Pharmaceutical Contract Manufacturing Services).

What are the key financial ratios of Aether Industries Limited?

Aether Industries Limited has a P/E of 101.8 and a return on equity of 9.81%.

What is the stock symbol of Aether Industries Limited?

Aether Industries Limited is listed on the NSE under the symbol AETHER and on the BSE under the scrip code 543534.

How has Aether Industries Limited's share price moved over the past year?

Aether Industries Limited's share price is up 127.8% over one year and up 6.1% over three months. Its 52-week range is ₹800.45 to ₹1,814.10.

What were Aether Industries Limited's latest quarterly results?

In Q2 FY27, Aether Industries Limited reported revenue of ₹347 Cr and net profit of ₹68 Cr, with basic EPS of ₹5.12 (consolidated, parsed from the company's exchange filing).

How have Aether Industries Limited's revenue and profit changed over the past year?

Aether Industries Limited reported revenue of ₹347 Cr in Q2 FY27, up 26.2% from ₹275 Cr in Q2 FY26 and up 6.3% from ₹327 Cr in Q1 FY27.

What is the promoter holding in Aether Industries Limited?

Promoters held 74.92% of Aether Industries Limited's shares as of Sept 2026, against 75.00% in Sept 2025 (−0.08 percentage points).

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.